Frequency of Pathogenic Germline Variants in BRCA1, BRCA2, PALB2, CHEK2 and TP53 in Ductal Carcinoma in Situ Diagnosed in Women Under the Age of 50 Years

Breast Cancer Research - United Kingdom
doi 10.1186/s13058-019-1143-y
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Prevalence of BRCA1 and BRCA2 Mutations in Women Diagnosed With Ductal Carcinoma in Situ

JAMA - Journal of the American Medical Association
Medicine
2005English

Founder BRCA1/BRCA2/PALB2 Pathogenic Variants in French-Canadian Breast Cancer Cases and Controls

Scientific Reports
Multidisciplinary
2020English

Mutations in BRCA1, BRCA2, and PALB2, and a Panel of 50 Cancer-Associated Genes in Pancreatic Ductal Adenocarcinoma

Scientific Reports
Multidisciplinary
2018English

Risk of Contralateral Breast Cancer in Women With and Without Pathogenic Variants in BRCA1, BRCA2, and TP53 Genes in Women With Very Early-Onset (<36 Years) Breast Cancer

Cancers
Cancer ResearchOncology
2020English

Physical Activity Behaviors in Women With Newly Diagnosed Ductal Carcinoma-In-Situ

Annals of Surgical Oncology
OncologySurgery
2009English

The Germline Mutational Landscape of BRCA1 and BRCA2 in Brazil

Scientific Reports
Multidisciplinary
2018English

PALB2 Links BRCA1 and BRCA2 in the DNA-Damage Response

Current Biology
GeneticsMolecular BiologyBiochemistryBiological SciencesNeuroscienceAgricultural
2009English

Novel Germline Mutations and Unclassified Variants of BRCA1 and BRCA2 Genes in Chinese Women With Familial Breast/Ovarian Cancer

BMC Cancer
Cancer ResearchOncologyGenetics
2016English

Trends in Treatment Patterns and Clinical Outcomes in Young Women Diagnosed With Ductal Carcinoma in Situ

Clinical Breast Cancer
Cancer ResearchOncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy